AstraZeneca Restructures Following the Strongest Year-end Results in a Decade, an Industrial Info Market Brief
AstraZeneca Restructures Following the Strongest Year-end Results in a Decade, an Industrial Info Market Brief
Attachment: AstraZeneca Manufacturing Sites
Pharmaceutical company AstraZeneca closed out 2018 with a 4% boost in product sales to $21 billion.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- México registra inversiones por 2 mil millones de dólares en el sector farm...
- Mexico Registers US$2 Billion in Pharmaceutical Investments
- New England Sees $27 Billion in Projects Under Construction
- Pharma, Manufacturing Lead Indiana to $21.6 Billion of Projects Under Const...
- India Aims to Reduce Dependence on China for Pharma Market